Table of Contents

|Articles|January 1, 2004

Pharmaceutical Executive

Pharmaceutical Executive-01-01-2004

Table of Contents

External Link - article-80918.pdf

Articles in this issue

over 22 years ago

Article

PE's Annual Sales and Marketing Employment Survey: The Big Squeeze

over 22 years ago

Article

Streamlining For Success with Fred Price of BioMarin

over 22 years ago

Article

The Making of a New Disease

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Articles in this issue

Related Content

FDA Approves Skinvive by Juvéderm for Improvement of Neck Appearance

Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results

Finding the Data for Rare, Pediatric Therapies: Q&A with Lisa Bollinger

Novavax's Strategy Across Commercial, R&D, and Partnerships

Partnering in Non-Opioids: Q&A with Dr. Edward Littler and Dave Watson

Trending on PharmExec

Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results

Pharma Roundup: FDA Approves Truqap Plus Abiraterone and Prednisone, FDA Approves Keytruda and Keytruda Qlex Each in Combination with Welireg

Partnering in Non-Opioids: Q&A with Dr. Edward Littler and Dave Watson

Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg

Novavax's Strategy Across Commercial, R&D, and Partnerships